MetaADEDB 2.0 @ LMMD
Pamidronate
(CEYUIFJWVHOCPP-UHFFFAOYSA-L)
Structure
SMILES
NCCC(P(=O)(O)[O-])(P(=O)(O)[O-])O.[Na+].[Na+]
Molecular Formula:
C3H9NNa2O7P2
Molecular Weight:
279.033
Log P:
-0.0866
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
4
TPSA:
186.59
CAS Number(s):
57248-88-1
Synonym(s)
1.
Pamidronate
2.
(3-Amino-1-hydroxypropylidene)-1,1-biphosphonate
3.
1-Hydroxy-3-aminopropane-1,1-diphosphonic acid
4.
AHPrBP
5.
Amidronate
6.
Amino-1-hydroxypropane-1,1-diphosphonate
7.
Aminohydroxypropylidene Diphosphonate
8.
Aminopropanehydroxydiphosphonate
9.
Aredia
10.
Pamidronate Calcium
11.
Pamidronate Disodium
12.
Pamidronate Monosodium
13.
Pamidronic Acid
14.
1 Hydroxy 3 aminopropane 1,1 diphosphonic acid
15.
Amino 1 hydroxypropane 1,1 diphosphonate
External Link(s)
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1PainFAERS: 449
Canada Vigilance: 14
Canada Vigilance
US FAERS
2Osteonecrosis of JawFAERS: 353
Canada Vigilance: 7
Canada Vigilance
US FAERS
3AnxietyFAERS: 203US FAERS
4Tooth ExtractionFAERS: 142US FAERS
5AnhedoniaFAERS: 117US FAERS
6InfectionFAERS: 93US FAERS
7OsteomyelitisFAERS: 84
Canada Vigilance: 1
Canada Vigilance
US FAERS
8DisabilityFAERS: 80US FAERS
9DeformityFAERS: 67US FAERS
10SequestrectomyFAERS: 50US FAERS
11Physical disabilityFAERS: 48US FAERS
12Emotional distressFAERS: 45US FAERS
13General physical health deteriorationFAERS: 43US FAERS
14OverdoseFAERS: 37US FAERS
15Wound DebridementFAERS: 35US FAERS
16Back PainFAERS: 31US FAERS
17Blood creatinine increasedFAERS: 26US FAERS
18SwellingFAERS: 26US FAERS
19Primary sequestrumFAERS: 25US FAERS
20ArthralgiaFAERS: 24
Canada Vigilance: 2
Canada Vigilance
US FAERS
21AtelectasisFAERS: 23US FAERS
22Bone lesionFAERS: 23US FAERS
23ErythemaFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
24NauseaFAERS: 23
Canada Vigilance: 4
Canada Vigilance
US FAERS
25FractureFAERS: 22US FAERS
26Life expectancy shortenedFAERS: 21US FAERS
27OsteolysisFAERS: 20US FAERS
28Bone painFAERS: 19
Canada Vigilance: 2
Canada Vigilance
US FAERS
29CellulitisFAERS: 19US FAERS
30DiscomfortFAERS: 19US FAERS
31Intervertebral Disc DegenerationFAERS: 19US FAERS
32FatigueFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
33LymphadenopathyFAERS: 18US FAERS
34Chest PainFAERS: 17US FAERS
35MyalgiaFAERS: 17US FAERS
36Malignant neoplasm progressionFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
37Oral painFAERS: 16US FAERS
38Pathological fractureFAERS: 16US FAERS
39Weight decreasedFAERS: 16US FAERS
40ActinomycosisFAERS: 15US FAERS
41HeadacheFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
42Nephrotic SyndromeFAERS: 15US FAERS
43ToothacheFAERS: 15US FAERS
44ChillsFAERS: 14US FAERS
45ConjunctivitisFAERS: 14US FAERS
46InflammationFAERS: 14US FAERS
47OsteopeniaFAERS: 14US FAERS
48VomitingFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
49Bone swellingFAERS: 13US FAERS
50Soft Tissue InfectionFAERS: 13US FAERS
51Bone density decreasedFAERS: 12US FAERS
52HypophagiaFAERS: 12US FAERS
53Mastication disorderFAERS: 12US FAERS
54Wound dehiscenceFAERS: 12US FAERS
55Abdominal PainFAERS: 11US FAERS
56CardiomegalyFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
57DizzinessFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
58Endodontic procedureFAERS: 11US FAERS
59OsteitisFAERS: 11US FAERS
60PneumoniaFAERS: 11US FAERS
61Soft tissue inflammationFAERS: 11US FAERS
62Tooth LossFAERS: 11US FAERS
63AlopeciaFAERS: 10US FAERS
64Blood parathyroid hormone increasedFAERS: 10US FAERS
65BronchitisFAERS: 10US FAERS
66ConstipationFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
67DebridementFAERS: 10US FAERS
68ExtravasationFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
69Multiple MyelomaFAERS: 10US FAERS
70OsteoporosisFAERS: 10US FAERS
71TinnitusFAERS: 10US FAERS
72Blood lactate dehydrogenase increasedFAERS: 9US FAERS
73Neck PainFAERS: 9US FAERS
74ProteinuriaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
75Respiratory distressFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
76ThrombophlebitisFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
77AstheniaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
78Blood alkaline phosphatase increasedFAERS: 8US FAERS
79Drug administration errorFAERS: 8US FAERS
80Fistula repairFAERS: 8US FAERS
81MalaiseFAERS: 8
Canada Vigilance: 3
Canada Vigilance
US FAERS
82Medication ErrorFAERS: 8US FAERS
83Musculoskeletal PainFAERS: 8US FAERS
84Oral Cavity FistulaFAERS: 8US FAERS
85Pericardial effusionFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
86Tooth InfectionFAERS: 8US FAERS
87Alanine Aminotransferase IncreasedFAERS: 7US FAERS
88ArteriosclerosisFAERS: 7US FAERS
89ArthritisFAERS: 7US FAERS
90Aspartate Aminotransferase IncreasedFAERS: 7US FAERS
91BlindnessFAERS: 7US FAERS
92CataractFAERS: 7US FAERS
93Deep Vein ThrombosisFAERS: 7US FAERS
94Dental cariesFAERS: 7US FAERS
95Exposed bone in jawFAERS: 7US FAERS
96Focal glomerulosclerosisFAERS: 7US FAERS
97Renal cystFAERS: 7US FAERS
98Atypical femur fractureFAERS: 6
Canada Vigilance: 19
Canada Vigilance
US FAERS
99CholecystitisFAERS: 6US FAERS
100Compression fractureFAERS: 6US FAERS
101Disease ProgressionFAERS: 6US FAERS
102DiverticulumFAERS: 6US FAERS
103Drug exposure during pregnancyFAERS: 6US FAERS
104DyspepsiaFAERS: 6US FAERS
105Febrile NeutropeniaFAERS: 6US FAERS
106Infusion site reactionFAERS: 6US FAERS
107Injection Site ReactionFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
108Injection site extravasationFAERS: 6US FAERS
109Musculoskeletal chest painFAERS: 6US FAERS
110Oral infectionFAERS: 6US FAERS
111OsteosclerosisFAERS: 6US FAERS
112PurulenceFAERS: 6US FAERS
113StomatitisFAERS: 6US FAERS
114TachycardiaFAERS: 6US FAERS
115ThrombosisFAERS: 6US FAERS
116Atrial FibrillationFAERS: 5US FAERS
117Blood albumin decreasedFAERS: 5US FAERS
118Blood chloride decreasedFAERS: 5US FAERS
119Blood phosphorus increasedFAERS: 5US FAERS
120Blood urea increasedFAERS: 5US FAERS
121Bone trimmingFAERS: 5US FAERS
122BradycardiaFAERS: 5US FAERS
123Depressed Level of ConsciousnessFAERS: 5US FAERS
124Drug ineffectiveFAERS: 5
Canada Vigilance: 13
Canada Vigilance
US FAERS
125Eye painFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
126Failure to ThriveFAERS: 5US FAERS
127LeukocytosisFAERS: 5US FAERS
128LymphangitisFAERS: 5US FAERS
129NecrosisFAERS: 5US FAERS
130NeutropeniaFAERS: 5US FAERS
131OsteotomyFAERS: 5US FAERS
132PancytopeniaFAERS: 5US FAERS
133Pelvic PainFAERS: 5US FAERS
134Purulent dischargeFAERS: 5US FAERS
135SinusitisFAERS: 5US FAERS
136Skin discomfortFAERS: 5US FAERS
137ThrombocytopeniaFAERS: 5US FAERS
138X-ray abnormalFAERS: 5US FAERS
139AbscessFAERS: 4US FAERS
140Acquired diaphragmatic eventrationFAERS: 4US FAERS
141Bone marrow depressionFAERS: 4US FAERS
142Creatinine renal clearance decreasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
143CystFAERS: 4US FAERS
144DeafnessFAERS: 4US FAERS
145DeliriumFAERS: 4US FAERS
146Dental discomfortFAERS: 4US FAERS
147Diastolic hypertensionFAERS: 4US FAERS
148DysuriaFAERS: 4US FAERS
149EpistaxisFAERS: 4US FAERS
150HypotensionFAERS: 4US FAERS
151Lipase increasedFAERS: 4US FAERS
152LymphopeniaFAERS: 4US FAERS
153Oral candidiasisFAERS: 4US FAERS
154Oropharyngeal painFAERS: 4US FAERS
155Osteitis DeformansFAERS: 4US FAERS
156PharyngitisFAERS: 4US FAERS
157PleurisyFAERS: 4US FAERS
158PneumonitisFAERS: 4US FAERS
159PolydipsiaFAERS: 4US FAERS
160PresyncopeFAERS: 4US FAERS
161PruritusFAERS: 4US FAERS
162Pulmonary congestionFAERS: 4US FAERS
163Renal tubular necrosisFAERS: 4US FAERS
164TetanyFAERS: 4US FAERS
165UlcerFAERS: 4US FAERS
166Urinary RetentionFAERS: 4US FAERS
167UrticariaFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
168Ventricular hypokinesiaFAERS: 4US FAERS
169kyphosisFAERS: 4US FAERS
170Actinic keratosisFAERS: 3US FAERS
171AlveoloplastyFAERS: 3US FAERS
172AnorexiaFAERS: 3US FAERS
173Atrial FlutterFAERS: 3US FAERS
174Basal cell carcinomaFAERS: 3US FAERS
175Benign bone neoplasmFAERS: 3US FAERS
176Biopsy bone abnormalFAERS: 3US FAERS
177Blood magnesium decreasedFAERS: 3US FAERS
178Blood potassium decreasedFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
179Blood sodium decreasedFAERS: 3US FAERS
180Bone SarcomaFAERS: 3US FAERS
181Bone density increasedFAERS: 3US FAERS
182Bone erosionFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
183BronchospasmFAERS: 3US FAERS
184Cerebrovascular accidentFAERS: 3US FAERS
185Chronic sinusitisFAERS: 3US FAERS
186Denture wearerFAERS: 3US FAERS
187Device breakageFAERS: 3US FAERS
188Drug exposure before pregnancyFAERS: 3US FAERS
189Drug toxicityFAERS: 3US FAERS
190Duodenal UlcerFAERS: 3US FAERS
191Engraftment syndromeFAERS: 3US FAERS
192FolliculitisFAERS: 3US FAERS
193Gamma-Glutamyltransferase IncreasedFAERS: 3US FAERS
194GlaucomaFAERS: 3US FAERS
195HepatitisFAERS: 3US FAERS
196HypercapniaFAERS: 3US FAERS
197HyperkeratosisFAERS: 3US FAERS
198HypersensitivityFAERS: 3US FAERS
199Implant site inflammationFAERS: 3US FAERS
200Infusion site painFAERS: 3US FAERS
201Infusion site swellingFAERS: 3US FAERS
202Injection site necrosisFAERS: 3US FAERS
203Irritable Bowel SyndromeFAERS: 3US FAERS
204Joint swellingFAERS: 3US FAERS
205LipomaFAERS: 3US FAERS
206Loose toothFAERS: 3US FAERS
207Medical device removalFAERS: 3US FAERS
208Myeloma recurrenceFAERS: 3US FAERS
209NephrolithiasisFAERS: 3US FAERS
210NephrosclerosisFAERS: 3US FAERS
211Oropharyngeal candidiasisFAERS: 3US FAERS
212PneumothoraxFAERS: 3US FAERS
213Post procedural complicationFAERS: 3US FAERS
214Postoperative infectionFAERS: 3US FAERS
215Product use issueFAERS: 3US FAERS
216Protein total decreasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
217Protein urine presentFAERS: 3US FAERS
218Renal interstitial fibrosisFAERS: 3US FAERS
219ShockFAERS: 3US FAERS
220Stem cell transplantFAERS: 3US FAERS
221SyncopeFAERS: 3US FAERS
222Urethral StenosisFAERS: 3US FAERS
223UveitisFAERS: 3US FAERS
224VasculitisFAERS: 3US FAERS
225Ventricular hypertrophyFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
226Visual ImpairmentFAERS: 3
Canada Vigilance: 3
Canada Vigilance
US FAERS
227White blood cell count decreasedFAERS: 3US FAERS
228AbasiaFAERS: 2US FAERS
229AgranulocytosisFAERS: 2US FAERS
230AmnesiaFAERS: 2US FAERS
231Anaphylactic shockFAERS: 2US FAERS
232Anaplastic large cell lymphoma T- and null-cell typesFAERS: 2US FAERS
233AngioedemaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
234Ankylosing spondylitisFAERS: 2US FAERS
235AphasiaFAERS: 2US FAERS
236AscitesFAERS: 2US FAERS
237Atrial tachycardiaFAERS: 2US FAERS
238Atrophic vulvovaginitisFAERS: 2US FAERS
239Biopsy site unspecified abnormalFAERS: 2US FAERS
240BiopsyFAERS: 2US FAERS
241Blood amylase increasedFAERS: 2US FAERS
242Blood creatine phosphokinase increasedFAERS: 2US FAERS
243Blood glucose increasedFAERS: 2US FAERS
244Blood potassium increasedFAERS: 2US FAERS
245Blood pressure immeasurableFAERS: 2US FAERS
246Burning sensationFAERS: 2US FAERS
247BursitisFAERS: 2US FAERS
248CalcinosisFAERS: 2US FAERS
249Cardiac TamponadeFAERS: 2US FAERS
250Carpal Tunnel SyndromeFAERS: 2US FAERS
251CholelithiasisFAERS: 2US FAERS
252ColitisFAERS: 2US FAERS
253Concomitant disease progressionFAERS: 2US FAERS
254Dental examination abnormalFAERS: 2US FAERS
255Depressed moodFAERS: 2US FAERS
256Diabetes MellitusFAERS: 2US FAERS
257DiplopiaFAERS: 2US FAERS
258EczemaFAERS: 2US FAERS
259Electrolyte imbalanceFAERS: 2US FAERS
260EmpyemaFAERS: 2US FAERS
261EndocarditisFAERS: 2US FAERS
262Erectile dysfunctionFAERS: 2US FAERS
263ExcoriationFAERS: 2US FAERS
264Eye irritationFAERS: 2US FAERS
265Feeling abnormalFAERS: 2US FAERS
266GastritisFAERS: 2US FAERS
267Gingival RecessionFAERS: 2US FAERS
268GranulomaFAERS: 2US FAERS
269Growth retardationFAERS: 2US FAERS
270Hip surgeryFAERS: 2US FAERS
271Hypoaesthesia facialFAERS: 2US FAERS
272HypokinesiaFAERS: 2US FAERS
273HyporeflexiaFAERS: 2US FAERS
274IleusFAERS: 2US FAERS
275IncontinenceFAERS: 2US FAERS
276IndurationFAERS: 2US FAERS
277Inflammatory painFAERS: 2US FAERS
278Infusion Site ExtravasationFAERS: 2US FAERS
279Injection site phlebitisFAERS: 2US FAERS
280IntubationFAERS: 2US FAERS
281Leukocytoclastic vasculitisFAERS: 2US FAERS
282Lower respiratory tract infectionFAERS: 2US FAERS
283Lumbar radiculopathyFAERS: 2US FAERS
284LymphohistiocytosisFAERS: 2US FAERS
285MastoiditisFAERS: 2US FAERS
286MesenteritisFAERS: 2US FAERS
287Metastases to peripheral vascular systemFAERS: 2US FAERS
288MetastasisFAERS: 2US FAERS
289Metastatic NeoplasmFAERS: 2US FAERS
290MumpsFAERS: 2US FAERS
291MyositisFAERS: 2US FAERS
292Neutropenic colitisFAERS: 2US FAERS
293Numb chin syndromeFAERS: 2US FAERS
294Osteogenesis ImperfectaFAERS: 2US FAERS
295OsteopetrosisFAERS: 2US FAERS
296Oxygen saturation abnormalFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
297PancreatitisFAERS: 2US FAERS
298ParathyroidectomyFAERS: 2US FAERS
299PeriostitisFAERS: 2US FAERS
300Peripheral arterial occlusive diseaseFAERS: 2US FAERS
301PlasmacytomaFAERS: 2US FAERS
302Pleuritic painFAERS: 2US FAERS
303PolyneuropathyFAERS: 2US FAERS
304Positron emission tomogram abnormalFAERS: 2US FAERS
305Product use in unapproved indicationFAERS: 2
Canada Vigilance: 15
Canada Vigilance
US FAERS
306PsoriasisFAERS: 2US FAERS
307Pulmonary Valve StenosisFAERS: 2US FAERS
308Radial nerve palsyFAERS: 2US FAERS
309Renal tubular atrophyFAERS: 2US FAERS
310Respiratory FailureFAERS: 2US FAERS
311Retroperitoneal lymphadenopathyFAERS: 2US FAERS
312Rotator cuff syndromeFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
313SepsisFAERS: 2US FAERS
314Skin ErosionFAERS: 2US FAERS
315Skin UlcerFAERS: 2US FAERS
316SpondylolisthesisFAERS: 2US FAERS
317Squamous cell carcinomaFAERS: 2US FAERS
318Suture insertionFAERS: 2US FAERS
319SynovitisFAERS: 2US FAERS
320Systolic hypertensionFAERS: 2US FAERS
321T-Cell LymphomaFAERS: 2US FAERS
322Transaminases increasedFAERS: 2US FAERS
323Urinary tract infectionFAERS: 2US FAERS
324Vaginal DischargeFAERS: 2US FAERS
325Venous ThrombosisFAERS: 2US FAERS
326Vertebral foraminal stenosisFAERS: 2US FAERS
327Visual disturbanceFAERS: 2US FAERS
328nervous system disorderFAERS: 2US FAERS
329Abscess soft tissueFAERS: 1US FAERS
330AcanthosisFAERS: 1US FAERS
331Activities of daily living impairedFAERS: 1US FAERS
332AdenocarcinomaFAERS: 1US FAERS
333Adrenocortical insufficiency chronicFAERS: 1US FAERS
334AgitationFAERS: 1US FAERS
335Alanine aminotransferase abnormalFAERS: 1US FAERS
336AnisocytosisFAERS: 1US FAERS
337Antibiotic ProphylaxisFAERS: 1US FAERS
338ArthropathyFAERS: 1US FAERS
339AsthmaFAERS: 1US FAERS
340Axonal neuropathyFAERS: 1US FAERS
341Back disorderFAERS: 1US FAERS
342Bacterial disease carrierFAERS: 1US FAERS
343Biopsy gingivalFAERS: 1US FAERS
344Biopsy kidney abnormalFAERS: 1US FAERS
345Biopsy parathyroid gland abnormalFAERS: 1US FAERS
346Biopsy skin abnormalFAERS: 1US FAERS
347Bladder DiverticulumFAERS: 1US FAERS
348Blood 25-hydroxycholecalciferol decreasedFAERS: 1US FAERS
349Blood alkaline phosphatase decreasedFAERS: 1US FAERS
350Blood bilirubin unconjugated increasedFAERS: 1US FAERS
351Blood calcium abnormalFAERS: 1US FAERS
352Blood immunoglobulin M decreasedFAERS: 1US FAERS
353Blood parathyroid hormoneFAERS: 1US FAERS
354Blood parathyroid hormone decreasedFAERS: 1US FAERS
355Blood phosphorus decreasedFAERS: 1US FAERS
356Blood pressure fluctuationFAERS: 1US FAERS
357Bone fragmentationFAERS: 1US FAERS
358Cardiac ArrestFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
359Catheter related complicationFAERS: 1US FAERS
360Catheter sepsisFAERS: 1US FAERS
361Central venous catheter removalFAERS: 1US FAERS
362Cerebral InfarctionFAERS: 1US FAERS
363Cerebral atrophyFAERS: 1US FAERS
364Cervicobrachial syndromeFAERS: 1US FAERS
365Chest discomfortFAERS: 1US FAERS
366CholangitisFAERS: 1US FAERS
367CholestasisFAERS: 1US FAERS
368Concomitant disease aggravatedFAERS: 1US FAERS
369Cor pulmonaleFAERS: 1US FAERS
370Coronary angioplastyFAERS: 1US FAERS
371CystoceleFAERS: 1US FAERS
372Cytokine stormFAERS: 1US FAERS
373Detachment of retinal pigment epitheliumFAERS: 1US FAERS
374Device expulsionFAERS: 1US FAERS
375Device material issueFAERS: 1US FAERS
376Device related infectionFAERS: 1US FAERS
377Diabetic KetoacidosisFAERS: 1US FAERS
378Diastolic dysfunctionFAERS: 1US FAERS
379DiphtheriaFAERS: 1US FAERS
380Disease recurrenceFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
381Disseminated Intravascular CoagulationFAERS: 1US FAERS
382DissociationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
383DiverticulitisFAERS: 1US FAERS
384Drug ToleranceFAERS: 1US FAERS
385Drug exposure via breast milkFAERS: 1US FAERS
386DuodenitisFAERS: 1US FAERS
387DysarthriaFAERS: 1US FAERS
388DysgeusiaFAERS: 1US FAERS
389DysphoniaFAERS: 1US FAERS
390Eating disorder symptomFAERS: 1US FAERS
391Economic problemFAERS: 1US FAERS
392Endometrial HyperplasiaFAERS: 1US FAERS
393Endometrial hypertrophyFAERS: 1US FAERS
394Enterococcal infectionFAERS: 1US FAERS
395EpididymitisFAERS: 1US FAERS
396EpiduritisFAERS: 1US FAERS
397Epiphyseal injuryFAERS: 1US FAERS
398Exploratory operationFAERS: 1US FAERS
399Eye inflammationFAERS: 1US FAERS
400Facial PainFAERS: 1US FAERS
401Failure of implantFAERS: 1US FAERS
402FibrosisFAERS: 1US FAERS
403FlushingFAERS: 1US FAERS
404Gamma-glutamyltransferase abnormalFAERS: 1US FAERS
405GammopathyFAERS: 1US FAERS
406GastrinomaFAERS: 1US FAERS
407Gastrointestinal PainFAERS: 1US FAERS
408GingivitisFAERS: 1US FAERS
409HalitosisFAERS: 1US FAERS
410Hepatojugular refluxFAERS: 1US FAERS
411HydronephrosisFAERS: 1US FAERS
412HyperparathyroidismFAERS: 1US FAERS
413HyperphagiaFAERS: 1US FAERS
414HyperplasiaFAERS: 1US FAERS
415HypoparathyroidismFAERS: 1US FAERS
416HypoxiaFAERS: 1US FAERS
417ImmobileFAERS: 1US FAERS
418Implant site dischargeFAERS: 1US FAERS
419Implant site painFAERS: 1US FAERS
420Inappropriate affectFAERS: 1US FAERS
421Inappropriate schedule of drug administrationFAERS: 1US FAERS
422Incorrect drug administration durationFAERS: 1US FAERS
423Incorrect route of drug administrationFAERS: 1US FAERS
424Inflammatory marker increasedFAERS: 1US FAERS
425Infusion site erythemaFAERS: 1US FAERS
426Infusion site thrombosisFAERS: 1US FAERS
427Injection site erythemaFAERS: 1US FAERS
428Injection site inflammationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
429Injection site painFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
430Injection site ulcerFAERS: 1US FAERS
431Intentional drug misuseFAERS: 1US FAERS
432IntertrigoFAERS: 1US FAERS
433IridocyclitisFAERS: 1US FAERS
434IritisFAERS: 1US FAERS
435Jaw lesion excisionFAERS: 1US FAERS
436Joint Range of Motion DecreasedFAERS: 1US FAERS
437KeratopathyFAERS: 1US FAERS
438Left Ventricular HypertrophyFAERS: 1US FAERS
439Left atrial dilatationFAERS: 1US FAERS
440LeukopeniaFAERS: 1US FAERS
441Limb asymmetryFAERS: 1US FAERS
442Limb injuryFAERS: 1US FAERS
443LordosisFAERS: 1US FAERS
444LymphadenitisFAERS: 1US FAERS
445Lymphocyte count decreasedFAERS: 1US FAERS
446MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
447MalnutritionFAERS: 1US FAERS
448MastectomyFAERS: 1US FAERS
449Maxillofacial operationFAERS: 1US FAERS
450Mediastinal massFAERS: 1US FAERS
451Memory impairmentFAERS: 1US FAERS
452Meningitis herpesFAERS: 1US FAERS
453MeningitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
454Mental impairmentFAERS: 1US FAERS
455Metastases to adrenalsFAERS: 1US FAERS
456Metastases to pelvisFAERS: 1US FAERS
457Micrographic skin surgeryFAERS: 1US FAERS
458Muscle CrampFAERS: 1US FAERS
459Muscle enzyme increasedFAERS: 1US FAERS
460Musculoskeletal stiffnessFAERS: 1US FAERS
461Myocardial InfarctionFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
462MyopathyFAERS: 1US FAERS
463Nasal sinus drainageFAERS: 1US FAERS
464Neonatal disorderFAERS: 1US FAERS
465Nerve injuryFAERS: 1US FAERS
466Neuropathic ulcerFAERS: 1US FAERS
467NocturiaFAERS: 1US FAERS
468Noninfectious peritonitisFAERS: 1US FAERS
469ObesityFAERS: 1US FAERS
470OnycholysisFAERS: 1US FAERS
471OnychomycosisFAERS: 1US FAERS
472Oral mucosal erythemaFAERS: 1US FAERS
473OsteomalaciaFAERS: 1US FAERS
474OsteoradionecrosisFAERS: 1US FAERS
475PCO2 increasedFAERS: 1US FAERS
476Pain of skinFAERS: 1US FAERS
477PallorFAERS: 1US FAERS
478PalpitationsFAERS: 1US FAERS
479Pancreatic NeoplasmFAERS: 1US FAERS
480ParakeratosisFAERS: 1US FAERS
481ParaparesisFAERS: 1US FAERS
482Pelvic prolapseFAERS: 1US FAERS
483Peptic UlcerFAERS: 1US FAERS
484Performance status decreasedFAERS: 1US FAERS
485PericarditisFAERS: 1US FAERS
486Plastic surgery to the faceFAERS: 1US FAERS
487PolyarthritisFAERS: 1US FAERS
488Poor dental conditionFAERS: 1US FAERS
489Post procedural infectionFAERS: 1US FAERS
490Pre-EclampsiaFAERS: 1US FAERS
491Premature MenopauseFAERS: 1US FAERS
492Procalcitonin increasedFAERS: 1US FAERS
493Procedural complicationFAERS: 1US FAERS
494Prostatic calcificationFAERS: 1US FAERS
495Prosthesis ImplantationFAERS: 1US FAERS
496PseudarthrosisFAERS: 1US FAERS
497Pulmonary EmbolismFAERS: 1US FAERS
498Pulmonary FibrosisFAERS: 1US FAERS
499Pulmonary HypertensionFAERS: 1US FAERS
500Pulmonary granulomaFAERS: 1US FAERS
501Quality of life decreasedFAERS: 1US FAERS
502Radicular painFAERS: 1US FAERS
503Rash erythematousFAERS: 1US FAERS
504Rectal polypFAERS: 1US FAERS
505RectoceleFAERS: 1US FAERS
506RegurgitationFAERS: 1US FAERS
507Renal cancer metastaticFAERS: 1US FAERS
508Renal tubular disorderFAERS: 1US FAERS
509Respiratory arrestFAERS: 1US FAERS
510Respiratory tract congestionFAERS: 1US FAERS
511Restrictive pulmonary diseaseFAERS: 1US FAERS
512Reticulocyte count decreasedFAERS: 1US FAERS
513Salivary gland painFAERS: 1US FAERS
514Salmonella sepsisFAERS: 1US FAERS
515ScleritisFAERS: 1US FAERS
516Secondary sequestrumFAERS: 1US FAERS
517Serotonin SyndromeFAERS: 1US FAERS
518Skeletal dysplasiaFAERS: 1US FAERS
519Skin lesionFAERS: 1US FAERS
520Skin necrosisFAERS: 1US FAERS
521Soft tissue massFAERS: 1US FAERS
522SomnolenceFAERS: 1US FAERS
523Spinal X-ray abnormalFAERS: 1US FAERS
524SplenomegalyFAERS: 1US FAERS
525StressFAERS: 1US FAERS
526Subcutaneous noduleFAERS: 1US FAERS
527SubileusFAERS: 1US FAERS
528Synovial CystFAERS: 1US FAERS
529TalipesFAERS: 1US FAERS
530Teeth brittleFAERS: 1US FAERS
531TenosynovitisFAERS: 1US FAERS
532Therapy non-responderFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
533ThirstFAERS: 1US FAERS
534Throat irritationFAERS: 1US FAERS
535ThyroidectomyFAERS: 1US FAERS
536Toxic Optic NeuropathyFAERS: 1US FAERS
537TransplantFAERS: 1US FAERS
538TremorFAERS: 1US FAERS
539TrismusFAERS: 1US FAERS
540UnderweightFAERS: 1US FAERS
541Unevaluable eventFAERS: 1US FAERS
542Unresponsive to verbal stimuliFAERS: 1US FAERS
543Urinary IncontinenceFAERS: 1US FAERS
544Urinary hesitationFAERS: 1US FAERS
545Vaginal mycosisFAERS: 1US FAERS
546Vein painFAERS: 1US FAERS
547Venous occlusionFAERS: 1US FAERS
548Vertebral column massFAERS: 1US FAERS
549VertigoFAERS: 1US FAERS
550Vitamin D DeficiencyFAERS: 1US FAERS
551WheezingFAERS: 1US FAERS
552Wound closureFAERS: 1US FAERS
553Wrong technique in drug usage processFAERS: 1US FAERS
554X-ray limb abnormalFAERS: 1US FAERS
555jaundiceFAERS: 1US FAERS
556Acute kidney injuryCanada Vigilance: 1Canada Vigilance
557Drug ineffective for unapproved indicationCanada Vigilance: 13Canada Vigilance
558FasciitisCanada Vigilance: 1Canada Vigilance
559HemiparesisCanada Vigilance: 1Canada Vigilance
560HordeolumCanada Vigilance: 1Canada Vigilance
561InfluenzaCanada Vigilance: 1Canada Vigilance
562Muscle SpasticityCanada Vigilance: 1Canada Vigilance
563Optic NeuritisCanada Vigilance: 2Canada Vigilance
564Orbital MyositisCanada Vigilance: 1Canada Vigilance
565ParaplegiaCanada Vigilance: 2Canada Vigilance
566PhlebitisCanada Vigilance: 2Canada Vigilance
567Vein collapseCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120269

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.